Why insider trading matters?

Numerous studies have examined whether there is evidence that U.S. insiders systematically trade on private information despite the legal deterrence. The consensus appears to be that insider purchases (but not sales) tend to be followed by positive abnormal stock price performance, particularly for small growth stocks.

- Prof. B. Espen Eckbo, Dartmouth College
Edesa Biotech, Inc. (EDSA)
Sector: Healthcare; Industry: Biotechnology

Edesa Biotech, Inc., a clinical-stage biopharmaceutical company, engages in the development and advancement of treatments for dermatological and gastrointestinal indications. Edesa Biotech, Inc. has a collaborative research project with the National Research Council of Canada to develop novel immunotherapies for vitiligo, as well as other indications; and Light Chain Bioscience for the development and commercialization of two Phase 2-ready biologic drug candidates for various therapeutic, prophylactic, and diagnostic applications. The company was founded in 2015 and is headquartered in Markham, Canada.


Trade Date Insider Title Buy/Sell #Shares Price Value Option
2021-02-18 OAKES FRANK R. Director Sell 7,992 $7.25 $57,942 No
2019-09-11 OAKES FRANK R. Director Sell 1,809 $5.72 $10,345 No
2019-03-06 OAKES FRANK R. President & CEO Sell 4,000 $1.25 $5,000 No
2018-10-12 OAKES FRANK R. President & CEO Sell 3,000 $1.31 $3,930 No

Insider Smart

Axsome Therapeutics, Inc (AXSM) - AXSM shows the power of an #allgreen stock, no insider selling, great management great company, if you follow the insiders last year and pick up around $25, the 52 week high is $100+.

Insider Smart

Upwork Inc (UPWK) - GRETSCH GREGORY C. Director of Upwork, made a bulk buy of 500K shares right before the big gap up, which is also the largest buy of the past 12 months.